venBio Global Strategic Fund III L.P. 13D/13G Filings for CinCor Pharma, Inc. (CINC)

venBio Global Strategic Fund III L.P. 13D and 13G filings for CinCor Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-09-26
4:18 pm
Sale		 2022-01-11 13G CinCor Pharma, Inc.
CINC		 venBio Global Strategic Fund III L.P. 1,862,256
4.900%		 -118,450decrease
(-5.98%)		 Filing
2022-01-11
4:46 pm
Purchase		 2022-01-11 13G CinCor Pharma, Inc.
CINC		 venBio Global Strategic Fund III L.P. 1,980,706
5.600%		 1,980,706increase
(New Position)		 Filing